Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Cert. of designation
Filed Chapter 11
Director departure
Appointed director
Quarterly results
|
|
Nuo Therapeutics, Inc. (AURX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| SHEEDY CHARLES E (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Bought 62,500 shares
@ $2, valued at
$125k
|
|
| 08/03/2023 |
4
| CLAUSEN PETER (CSO/COO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 25,000 shares
@ $2, valued at
$50k
|
|
| 08/03/2023 |
4
| Pittman Scott M. (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $2, valued at
$200k
|
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
3/A
| CLAUSEN PETER (CSO/COO) has filed a Form 3/A on Nuo Therapeutics, Inc. |
| 06/15/2022 |
4
| CLAUSEN PETER (CSO/COO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.75, valued at
$206.3k
|
|
| 05/02/2022 |
4
| JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 10,532 shares
@ $1, valued at
$10.5k
|
|
| 05/02/2022 |
4
| CLAUSEN PETER (CSO/COO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 25,000 shares
@ $1, valued at
$25k
|
|
| 05/02/2022 |
4
| Pittman Scott M. (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $1, valued at
$100k
|
|
| 05/02/2022 |
4
| SHEEDY CHARLES E (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Bought 804,868 shares
@ $1, valued at
$804.9k
|
|
| 04/26/2022 |
3
| CLAUSEN PETER (CSO/COO) has filed a Form 3 on Nuo Therapeutics, Inc. |
| 04/26/2022 |
4
| Mintz Paul (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 26,666 options to buy
@ $0.5, valued at
$13.3k
Granted 75,000 options to buy
@ $0.75, valued at
$56.3k
|
|
| 04/26/2022 |
4
| WINZER C ERIC (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 36,666 options to buy
@ $0.5, valued at
$18.3k
Granted 75,000 options to buy
@ $0.75, valued at
$56.3k
|
|
| 04/26/2022 |
4
| CLAUSEN PETER (CSO/COO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 43,328 options to buy
@ $0.5, valued at
$21.7k
|
|
| 04/26/2022 |
4
| Pittman Scott M. (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 33,334 options to buy
@ $0.5, valued at
$16.7k
Granted 100,000 options to buy
@ $0.75, valued at
$75k
|
|
| 04/26/2022 |
4
| JORDEN DAVID EMERSON (CEO/CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 66,672 options to buy
@ $0.5, valued at
$33.3k
Granted 125,000 options to buy
@ $0.75, valued at
$93.8k
|
|
| 01/03/2019 |
4
| Atinsky Lawrence (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 62,500 options to buy
@ $0.4, valued at
$25k
|
|
| 01/03/2019 |
4
| JORDEN DAVID EMERSON (CEO, CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $0.4, valued at
$50k
|
|
| 01/03/2019 |
4
| Mintz Paul (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.4, valued at
$20k
|
|
| 01/03/2019 |
4
| Pittman Scott M. (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 62,500 options to buy
@ $0.4, valued at
$25k
|
|
| 01/03/2019 |
4
| CLAUSEN PETER (CSO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 81,250 options to buy
@ $0.4, valued at
$32.5k
|
|
| 01/03/2019 |
4
| WINZER C ERIC (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 68,750 options to buy
@ $0.4, valued at
$27.5k
|
|
| 08/13/2018 |
4
| Pittman Scott M. (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 121,875 options to buy
@ $0.4, valued at
$48.8k
|
|
| 08/13/2018 |
4
| Atinsky Lawrence (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 109,375 options to buy
@ $0.4, valued at
$43.8k
|
|
| 08/13/2018 |
4
| JORDEN DAVID EMERSON (CEO, CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 192,710 options to buy
@ $0.4, valued at
$77.1k
|
|
| 08/13/2018 |
4
| WINZER C ERIC (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 120,313 options to buy
@ $0.4, valued at
$48.1k
|
|
| 08/13/2018 |
4
| CLAUSEN PETER (CSO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 183,853 options to buy
@ $0.4, valued at
$73.5k
|
|
| 08/13/2018 |
4
| Mintz Paul (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 87,500 options to buy
@ $0.4, valued at
$35k
|
|
| 09/21/2017 |
4
| Boyalife Investment Fund I, Inc. (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Bought 3,150,000 shares
@ $0.2222, valued at
$699.9k
|
|
| 08/14/2017 |
4
| JORDEN DAVID EMERSON (CEO, CFO) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Bought 247,500 shares
@ $0.2222, valued at
$55k
|
|
| 08/14/2017 |
4
| Pittman Scott M. (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Bought 1,485,000 shares
@ $0.2222, valued at
$330k
Bought 560,000 shares
@ $0.5, valued at
$280k
|
|
| 08/14/2017 |
4
| SHEEDY CHARLES E (10% Owner) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Bought 5,220,000 shares
@ $0.2222, valued at
$1.2M
|
|
| 07/10/2017 |
4
| Mintz Paul (Director) has filed a Form 4 on Nuo Therapeutics, Inc.|
Txns:
| Granted 18,750 options to buy
@ $1, valued at
$18.8k
|
|
| 04/20/2017 |
3
| Mintz Paul (Director) has filed a Form 3 on Nuo Therapeutics, Inc. |
|
|
|